Flurbiprofen and Tenosynovitis - a phase IV clinical study of FDA data

Summary:

Tenosynovitis is reported as a side effect among people who take Flurbiprofen (flurbiprofen), especially for people who are female, 30-39 old, also take Ativan, and have Psoriatic arthropathy.

The phase IV clinical study analyzes which people have Tenosynovitis when taking Flurbiprofen. It is created by eHealthMe based on reports of 2,660 people who have side effects when taking Flurbiprofen from the FDA, and is updated regularly.

What is Flurbiprofen?

Flurbiprofen has active ingredients of flurbiprofen. It is often used in rheumatoid arthritis. eHealthMe is studying from 2,677 Flurbiprofen users. Check the latest studies of Flurbiprofen.

What is Tenosynovitis?

Tenosynovitis (inflammation of the fluid-filled sheath (called the synovium) that surrounds a tendon) is found to be associated with 457 drugs and 490 conditions by eHealthMe. Check the latest studies of Tenosynovitis.

On Jul, 13, 2026

2,660 people reported to have side effects when taking Flurbiprofen.
Among them, 18 people (0.68%) have Tenosynovitis.

Among these 18 people:

What is the gender of people who have Tenosynovitis when taking Flurbiprofen? *

female: 100 %
male: 0.0 %

What is the age of people who have Tenosynovitis when taking Flurbiprofen? *

What are other drugs people take besides Flurbiprofen? *

Xanax: 11 people, 61.11%
Enbrel: 11 people, 61.11%
Concerta: 11 people, 61.11%
Ativan: 11 people, 61.11%
Procaine Hydrochloride: 8 people, 44.44%
Methotrexate: 8 people, 44.44%
Inflectra: 8 people, 44.44%
Novocain: 3 people, 16.67%
Plaquenil: 2 people, 11.11%
Pantoprazole: 2 people, 11.11%

What are other side effects people have besides Tenosynovitis? *

Drug Ineffective: 18 people, 100.00%
Enthesopathy (disorder of entheses (bone attachments)): 18 people, 100.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 11 people, 61.11%
C-Reactive Protein Abnormal: 11 people, 61.11%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 11 people, 61.11%
Inflammation: 11 people, 61.11%
Joint Pain: 7 people, 38.89%
Back Pain: 7 people, 38.89%
Dactylitis (dactylitis or sausage digit is inflammation of an entire digit (a finger or toe), and can be painful): 7 people, 38.89%
Fatigue (feeling of tiredness): 7 people, 38.89%

What are the existing conditions these people have? *

Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 18 people, 100.00%
Ankylosing Spondylitis (type of arthritis affecting the spine): 2 people, 11.11%

* Approximation only. Some reports may have incomplete information.

Do you take Flurbiprofen and have Tenosynovitis?

- Check whether Tenosynovitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Flurbiprofen:

Flurbiprofen (2,677 reports)

Tenosynovitis treatments and more:

Tenosynovitis (4,673 reports)

Browse all side effects of Flurbiprofen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tenosynovitis:

Tenosynovitis (457 drugs)

Browse all the conditions that are associated with Tenosynovitis:

Tenosynovitis (490 conditions)

Related publications that referenced our studies

Yaylaci S, Kocayigit I, Genc A, Tamer A, Gunduz H, "Sinus bradycardia caused by flurbiprofen intoxication", Nigerian Journal of Cardiology, 2015 Jan .
Yaylaci S, Kocayigit I, Genc A, Tamer A, Gunduz H, "Sinus bradycardia caused by flurbiprofen intoxication", Nigerian Journal of Cardiology, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on flurbiprofen (the active ingredients of Flurbiprofen) and Flurbiprofen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.